---
trial_id: 1498
discovery_date: 2022-07-23 22:00:47.870093
date: 2022-07-23 22:00:47.870093
title: "A Randomized, Multicenter STudy to Evaluate the Effect of Secukinumab 300 mg s.c. Administered During 52 Weeks to Patients Suffering From New-onset Moderate to Severe Plaque Psoriasis as Early Intervention Compared to Standard Treatment With Narrow-b ..."
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct03020199'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
